Cytopathology laboratories are highly regulated, with many policies, procedures, and quality monitors. One important aspect of cytopathology fellowship training is training in laboratory management and quality assurance/quality improvement (QA/QI) skills. Laboratory management is one of the competencies listed in the cytopathology milestones developed by the Accreditation Council for Graduate Medical Education (ACGME) under Systems-Based Practice (SBP) in the evaluation of cytopathology fellows.
Teaching Laboratory Management and Quality Assurance/Quality Improvement Skills in a Cytopathology Fellowship Program
Cytopathology laboratories are highly regulated, with many policies, procedures, and quality monitors. One important aspect of cytopathology fellowship training is training in laboratory management and quality assurance/quality improvement (QA/QI) skills. Laboratory management is one of the competencies listed in the cytopathology milestones developed by the Accreditation Council for Graduate Medical Education (ACGME) under Systems-Based Practice (SBP) in the evaluation of cytopathology fellows. 1 Following the descriptors and targets under SBP items 1 through 5 in the milestones, we have developed and implemented the following teaching and evaluation methods for cytopathology fellows.
1) Didactic Lecture and Assigned Reading Material
In the first month of the fellowship, the fellowship director presents a "Cytopathology Lab Management" lecture to the fellows. The lecture provides a general introduction to cytopathology laboratory management, including an overview of various agencies and organizations that regulate the cytopathology laboratory and the regulations and guidelines the laboratory should follow; the qualifications and descriptions of the duties of various cytology laboratory personnel; policy and procedure manuals in the laboratory; and standard preanalytical, analytical, and postanalytical quality indicators used in gynecologic, nongynecologic, and fine-needle aspiration cytology. Coding and billing for Papanicolaou (Pap) tests, nongynecologic cytology, and fine-needle aspiration also are discussed, as well as competency assessment for cytotechnologists and cytopathologists. The lecture ends with a short discussion of safety in the cytopathology laboratory.
We found that an opening introductory lecture such as this builds a good foundation and knowledge base for the fellows. The lecture stresses the importance of laboratory management in the practice of cytopathology at the beginning of fellowship training. At the end of the lecture, the fellowship director establishes the expectations and lists the laboratory management and QA activities that are required for fellows to participate (see below).
The fellows also are assigned required reading material regarding cytology laboratory management in addition to the lecture. The required readings include the chapter regarding quality management in cytopathology in the recently published Quality Management in Anatomic Pathology and the chapter concerning laboratory management in Cytology: Diagnostic Principles and Clinical Correlates 2,3 as well as the Cytopathology Checklist 4 in the College of American Pathologists' accreditation program.
2) Direct Involvement in Laboratory Management and the QA Program
The fellows are involved in laboratory management and the QA program through daily activities as follows.
A. Routinely review 5-year look-back slides and 10% rescreening slides in Pap tests Participation in the quality review of Pap test slides allows the fellows to have direct exposure to and experience in this important QA activity. Because there is an overall decrease in Pap test volume in academic medical centers, the routine review of 5-year look-back slides and participation in 10% rescreening also enhances the educational experience of cytopathology fellows with regard to Pap tests.
It is important to note that these 5-year look-back reviews are officially performed by the cytology supervisor and/or cytopathology director, and the 10% rescreening cases are signed out by a cytotechnologist or a cytopathologist.
B. Review cytology-histology correlation cases in both gynecologic and nongynecologic cytology The cytopathology director always reviews the cytology-histology correlation cases with cytopathology fellows. Causes of discrepancy and their impact on patient management are discussed during the review of slides. Various ways with which to handle discordant cases also are discussed in the process.
C. Participate in interlaboratory comparison programs and documenting results
The cytopathology fellows participate in all gynecologic and nongynecologic interlaboratory comparison programs of the laboratory. They submit their answers to the fellowship director and receive feedback when the results are returned. The fellows get used to this regular educational/assessment activity during their training and are prepared to do the same in practice after graduation. The fellowship director also can use this as one of the tools for evaluating the diagnostic skills of fellows.
D. Regularly attend monthly cytology division meetings and quarterly cytology QA data presentations The cytopathology fellows are required to attend the monthly cytology division meeting, at which issues in the cytopathology laboratory are discussed, including personnel, technical, and service issues. Fellows learn the roles of each team member through these meetings. Important topics such as workload documentation for cytotechnologists and cytopathologists (including how to count slides) and monthly turnaround times are discussed routinely in these meetings. The policy of reporting "critical values" frequently is reviewed and discussed in the meeting.
The cytopathology fellows also are required to attend the quarterly cytology QA data presentation in the department. In this presentation, the cytology supervisor presents the current quality monitors for preanalytical, analytical, and postanalytical measures. For example, the preanalytical monitors include labeling errors and the rate of unsatisfactory Pap tests; the analytical monitors include the atypical squamous cells/squamous intraepithelial lesion ratio, cytology-histology correlation data, and turnaround time; and the postanalytical monitors include auditing of amended reports. A targeted threshold is listed for each monitor and if the target is not achieved, possible causes and action plans are discussed. The cytopathology fellows gain firsthand experience in the cytology QA program by attending the presentations.
E. Participate as a team member in a mock College of American Pathologists' inspection
A cytopathology fellow is required to participate as a team member in mock College of American Pathologists' inspections and inspect the cytopathology laboratory. The cytopathology supervisor reviews the entire College of American Pathologists cytopathology checklist with the cytopathology fellow during the mock inspection. The cytopathology fellows document and report the deficiencies they identify and propose an action plan for each deficiency.
F. Directly involved in troubleshooting when an issue occurs in the laboratory
The cytopathology director and supervisor routinely involve the cytopathology fellow in troubleshooting when unusual specimens or unusual situations occur in the laboratory. The fellow is expected to call the clinician, check the literature if necessary, and develop plans to solve the issue.
3) Perform a QI Project
The cytopathology fellow is required to perform a QI project during their fellowship training. They may develop a project by themselves, or they may be assigned to a project by the fellowship director. Their work may be submitted for presentation in regional and national meetings. For example, one fellow in our program performed a retrospective study on the accuracy of rapid on-site specimen evaluation in our laboratory to further improve the quality of service. The study identified weakness of rapid on-site specimen evaluation performance in certain organs and also weakness of its performance in certain individuals; an action plan was put in place and the quality was improved.
Health care quality is one of the components of the ACGME Clinical Learning Environment Review site visit program. The engagement of residents and fellows in QI activities is one of the health care quality pathways to excellence. In addition, training and experience in QI processes, including health care disparities, is a core requirement for residents in the new ACGME Common Program Requirements.
4) Test
Toward the end of their training, the fellows will take a written test on laboratory management provided by the fellowship director. The test questions include all knowledge and practices covered in the first didactic lecture and throughout training. The fellowship director will review the test with the fellows after completion. It also serves as the final review of the laboratory management training for cytopathology fellows.
We developed the above teaching and training methods in correspondence with the cytopathology milestones developed by the ACGME under SBPs in the evaluation of cytopathology fellows. We have received positive feedback from graduated fellows, some of whom function as cytopathology directors shortly after graduation and are competent in laboratory management due to the daily and extensive involvement in these activities during their fellowship training. We constantly are modifying and improving our training program every year. For example, we will start to include cytopathology fellows in the laboratory budgeting meetings within the next year so that they will recognize and understand the elements of a budget (capital budget vs operating budget). Because laboratory management and quality are integral parts of our practice, it is essential for cytopathology fellows to learn these skills before they finish training.
